InvestorsHub Logo

RobinF

04/15/14 6:26 PM

#26633 RE: sts66 #26631

That article came out two days after the agreement was made with Amarin so, it was too soon to mention Vascepa. No doubt, Vascepa will be part of their future marketing in this campaign for heart health.

BioChica

04/16/14 8:46 AM

#26646 RE: sts66 #26631

I agree, I reduced my consumption, because of the muscle cramp in my legs! Which stopped, when I stopped the Statin evening dose. Yes this article was advertisement for Pitvastatin.

Nukemtiltheyglow

04/16/14 3:49 PM

#26649 RE: sts66 #26631

sts: This statement says it all..... I'll do a BioBill and read between the lines.

"Up to 75% of Americans stop taking statins, the most commonly prescribed therapy, within the first year, demonstrating the clear need for more education and supportive resources."

You're forgetting "supportive resources" what the heck are those?

The ad may have been a plug for Livalo, but, the wording could mean any number of things. They've left the door open and could plug-in Vascaepa as a supportive resource. Especially if there's a combo being planned. Reducing the amount of statins people take is key. If what you guys say about the side effects. If those can be reduced then we have a winnah.....